On September 17, Shanghai Unicornshell Pharmaceutical Technology Co., Ltd. was invited to participate in the 22nd China-ASEAN Expo held in Nanning, Guangxi. During the event, Unicornshell engaged in in-depth discussions with ASEAN business delegates, while the Chongzuo Media Convergence Center featured a special report on the company's core products. Moving forward, Unicornshell will sign a strategic cooperation agreement with Chongzuo City to jointly advance the upgrading of the green pharmaceutical industry.

Co-hosted by China's Ministry of Commerce, the governments of the ten ASEAN member states, and the ASEAN Secretariat, this year's Expo centered on the theme “Win-Win Cooperation, Building a Modern Economic System.” Focusing on digital economy, green industries, and healthcare sectors, it attracted over a thousand enterprises from more than 40 countries and regions. On this high-profile international stage, Unicornshell showcased the technological prowess and developmental potential of Chinese pharmaceutical enterprises through its innovative achievements in plant-based pharmaceutical excipients.

Headquartered in Shanghai, Unicornshell specializes in the R&D, production, and sales of plant-based pharmaceutical excipients and innovative traditional Chinese medicine formulations. It has launched hydroxypropyl methylcellulose capsules (first generation) and hydroxypropyl starch capsules (second generation), widely used in pharmaceuticals and nutritional supplements. Through an industrial cluster model, the company drives the deep integration of smart manufacturing and new materials, empowering the transformation and upgrading of traditional pharmaceutical industries. It is committed to becoming an industry leader in the intelligent manufacturing of plant-based capsules.

At the exhibition, Unicornshell highlighted its plant-based hollow capsules and a series of innovative formulations, including new products like Ganoderma lucidum spore powder capsules. Their eco-friendly credentials and superior performance attracted significant attention from domestic and international buyers, leading to multiple cooperation intentions. Buyers from ASEAN countries such as Singapore, Indonesia, and Malaysia expressed strong interest in the products' performance and international certification advantages. As a company certified by the U.S. FDA, Halal, European BRC, GMP, and Kosher, Unicornshell possesses core competitiveness for international market access, laying a solid foundation for further expansion into ASEAN and Belt and Road markets.

Concurrently, the Chongzuo Media Convergence Center featured Unicornshell in a special report, highlighting the company's technological innovations and global expansion in the plant-based capsule sector. Following the expo, Unicornshell will formally sign a strategic cooperation agreement with Chongzuo City to collaborate on green pharmaceutical industry development and investment promotion, thereby supporting high-quality local economic growth.

Moving forward, Unicornshell will steadfastly uphold its mission of “promoting medication safety and safeguarding human health.” By seizing new opportunities in China-ASEAN cooperation, leveraging its technological edge in plant-based pharmaceutical excipients and international certification capabilities, the company will accelerate its overseas market expansion. This will facilitate the implementation of innovative achievements in ASEAN and Central Asian markets. With an even more open approach, Unicornshell will collaborate with regional partners to build a green and safe pharmaceutical excipient ecosystem, fostering a new landscape of mutual benefit and shared success.